For Improved Drug Safety

unbIAsed.Rx empowers you to make informed decisions: visualize clinical trials and research done on your drug and talk to your practitioner about potential risks for your health!


Start today!
60% of drug trials include a disproportionately low number of female participants [1]
Female patients have a 1.5- to 1.7-fold greater risk of developing an Adverse drug reaction [2]
As of 2016, 70% of biomedical experiments did not report sex as a variable of interest [3]

[1] National Academies of Sciences, Engineering, and Medicine. 2022. Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups.
[2] Rademaker M. Do women have more adverse drug reactions? Am J Clin Dermatol. 2001
[3] Sugimoto CR, Ahn Y-Y, Smith E, Macaluso B, Larivière V Factors affecting sex-related reporting in medical research: a cross-disciplinary bibliometric analysis

* Videos will not autoplay if your device is on battery-saver mode *

Motivation

Historically, drug testing has often focused on demographics that do not accurately represent the general population. This has led to post-market adverse effects that disproportionately affect underrepresented groups. The underrepresentation of women in clinical trials introduces significant biases, compromising the quality of women's healthcare and exposing them to a higher risk of adverse drug reactions.  

Despite known differences, there is currently limited reporting of sex differences in the published results of clinical trial research and data analysis by sex is not carried out consistently for therapeutic products.  

Our unique approach combines advanced machine learning, comprehensive data integration and visualization, and a user-friendly platform to address a critical gap in the pharmaceutical industry.  


Our Vision

Self-advocacy: Knowledge is Power

Empower patients to be their own advocates by providing easy access to relevant public drug information for meaningful discussions with healthcare practitioners.  

Assist patients and practitioners in making well-informed decisions about medications by offering predictive sex-based adverse reaction alerts.  

Raise awareness about the imbalances in clinical trials and the need for more inclusive research practices.  


Impact

Strengthening the Foundation for Equitable and Effective Healthcare

  • Drive the shift towards more effective clinical practices by ensuring diverse representation in clinical trials.  

  • Improve drug safety & patient outcomes by providing predictive insights on adverse reactions, helping to prevent negative health outcomes.  

  • Reduce healthcare costs by mitigating the risk of adverse drug reactions, leading to more effective treatment plans.  



Disclaimer

​​unbIAsed.Rx is not affiliated with any pharmaceutical companies and does not endorse drugs, diagnose patients, or recommend therapy. This resource is designed to assist licensed healthcare practitioners in caring for their patients, provide consumers with drug-specific information, and raise awareness of sex disparities in pharmaceuticals and the underrepresentation of women and gender-diverse individuals in clinical trials. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect as the drug information contained herein may be time sensitive.

Always consult with a healthcare professional before making any medical decisions or changes to your treatment plan. The information on this site is not a substitute for professional medical advice and healthcare practitioners should use their professional judgment in using the information provided.

By using this product, you acknowledge and accept these disclaimers and limitations.